Acute Vaginitis
Understanding Acute Vaginitis: Find information on vaginal inflammation, vaginal infection, and related symptoms, diagnosis codes, and clinical documentation for healthcare professionals. Learn about the causes, treatment, and management of acute vaginitis, including medical coding best practices and relevant healthcare resources.
Inflammation of the vagina, often caused by infection or irritation.
Itching, burning, discharge, redness, pain during intercourse or urination.
Primary care clinics, OBGYN offices, urgent care centers.
ICD-10 Code Families
Complete code families applicable to N76.0
When to use each related code
| Description | When to use |
|---|---|
| Inflammation of the vagina, often infectious. | Acute vaginal symptoms like itching, discharge, odor, or pain. Consider specific infections if identified. |
| Yeast infection of the vagina. | Vaginal itching, thick white discharge. Confirm with microscopy if needed. Code as candidiasis if culture positive. |
| Bacterial vaginosis, imbalance of vaginal flora. | Thin, grayish discharge with fishy odor. Use when other causes are ruled out. Code as vaginosis if confirmed by Amsel criteria or Nugent score. |
Best-practice checklist
- ✓Document onset date of vaginitis symptoms.
- ✓Describe vaginal discharge: color, odor, amount.
- ✓Note any associated symptoms: itching, burning, pain.
- ✓Record pelvic exam findings: erythema, edema, lesions.
- ✓Include diagnostic tests and results (e.g., wet mount, pH).
Common pitfalls to avoid
Coding acute vaginitis without specifying the cause (e.g., yeast, bacterial, trichomonas) can lead to rejected claims and inaccurate data.
Misdiagnosis between vaginitis (vagina) and vulvovaginitis (vulva and vagina) impacts code selection and treatment planning, posing audit risks.
Coding symptoms (e.g., discharge, itching) instead of the confirmed diagnosis of vaginitis leads to undercoding and data inaccuracies.
Best-practice tips
- 01Improve CDI: Document discharge, color, odor for accurate vaginitis coding.
- 02Medical coding: Use ICD-10 codes (N76.*, B37.3) based on etiology.
- 03Healthcare compliance: Ensure proper specimen collection, lab tests for diagnosis.
- 04Best practice: Rule out STIs, candidiasis, BV with appropriate testing.
- 05Prevent recurrence: Patient education on hygiene, safe sex practices.
Step-by-step checklist
- 1
Confirm vaginal discharge, itching, or burning (ICD-10 N76.0)
- 2
Rule out STIs (Chlamydia, Gonorrhea, Trichomonas) with testing
- 3
Evaluate vaginal pH and microscopy for bacterial vaginosis
- 4
Consider Candida infection if cottage cheese discharge present
- 5
Document symptoms, exam, tests, and diagnosis clearly for billing
Ready-to-paste narrative
Patient presents with complaints consistent with acute vaginitis, also known as vaginal inflammation or vaginal infection. Symptoms include vaginal discharge, itching, burning, irritation, and dyspareunia. The patient reports onset of symptoms approximately [duration] ago. The character of the vaginal discharge is described as [color, consistency, odor]. Associated symptoms such as urinary frequency, urgency, or dysuria were [present/absent]. The patient's past medical history includes [relevant medical history, e.g., diabetes, STIs, recent antibiotic use]. Gynecological history includes [menarche, last menstrual period, gravidity, parity, contraceptive use]. Physical examination reveals [erythema, edema, lesions, discharge characteristics]. A vaginal pH test was performed with a result of [pH value]. Wet mount microscopy revealed [microscopic findings, e.g., clue cells, budding yeast, trichomonads]. Based on the patient's presentation and clinical findings, the diagnosis of acute vaginitis is established. Differential diagnoses considered include [bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, atrophic vaginitis]. Treatment for [specific type of vaginitis] has been initiated with [medication, dosage, route of administration]. Patient education provided regarding hygiene practices, safe sex practices, and medication compliance. Follow-up appointment scheduled in [duration] to assess treatment response. ICD-10 code [appropriate ICD-10 code] is applied.
Common questions and answers
What are the key differential diagnosis considerations for acute vaginitis in adult women presenting with vaginal discharge and discomfort?+
Differential diagnosis of acute vaginitis in adult women with vaginal discharge and discomfort requires considering several conditions. Bacterial vaginosis (BV) often presents with a thin, homogenous, grayish-white discharge and a characteristic fishy odor. Vulvovaginal candidiasis (VVC), commonly known as a yeast infection, typically involves thick, white, cottage cheese-like discharge, intense pruritus, and burning. Trichomoniasis, a sexually transmitted infection, may manifest with a frothy, yellow-green discharge, vulvar irritation, and a strawberry cervix upon examination. Other less common causes include atrophic vaginitis, foreign body vaginitis, and allergic or irritant contact dermatitis. Accurate diagnosis hinges on a thorough patient history, including sexual history and medication use, a pelvic examination, and point-of-care or laboratory testing such as vaginal pH assessment, microscopy, and nucleic acid amplification tests (NAATs). Explore how combining these methods ensures a precise diagnosis and informs appropriate treatment strategies. Consider implementing a standardized diagnostic approach in your practice to effectively differentiate acute vaginitis etiologies.
How does point-of-care testing impact the management of acute vaginitis in a primary care setting, considering factors like cost-effectiveness and patient satisfaction?+
Point-of-care testing (POCT) can significantly enhance the management of acute vaginitis in primary care settings by providing rapid results and facilitating prompt treatment. Tests such as vaginal pH measurement, whiff test (amine odor test), and wet mount microscopy can often differentiate between bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis, enabling clinicians to initiate appropriate therapy during the patient's visit. This immediate intervention can improve patient satisfaction by alleviating symptoms quickly and reducing the need for follow-up visits. POCT can also be more cost-effective than sending samples to an external laboratory, especially considering the potential for reduced complications and improved patient adherence with immediate treatment. However, it is essential to be aware of the limitations of POCT, such as lower sensitivity and specificity compared to some laboratory tests. Learn more about incorporating POCT into your practice while considering factors like clinician training, quality control, and integration with electronic health records to optimize patient care and cost-effectiveness.
What are the evidence-based treatment recommendations for recurrent vulvovaginal candidiasis, and how can clinicians address potential antifungal resistance?+
Recurrent vulvovaginal candidiasis (RVVC), defined as four or more episodes within a year, poses a significant challenge for both patients and clinicians. Evidence-based treatment recommendations emphasize long-term antifungal maintenance therapy following an initial intensive treatment phase. Fluconazole, administered orally or intravaginally, is commonly used for maintenance therapy, typically for six months. However, it is crucial to consider potential antifungal resistance, particularly to azole antifungals. Clinicians should consider culture and susceptibility testing in cases of RVVC to guide treatment choices and identify non-albicans Candida species, which may be more resistant to azoles. Alternative antifungal agents, such as topical or oral itraconazole or terconazole, might be necessary for refractory cases. Patient education on preventative measures, including avoiding excessive antibiotic use, optimizing glycemic control in patients with diabetes, and minimizing the use of tight-fitting clothing and irritating hygiene products, is paramount. Consider implementing a comprehensive approach to RVVC management that combines antifungal therapy with lifestyle modifications and addresses potential antifungal resistance to improve patient outcomes. Learn more about emerging research on alternative therapies and strategies for managing antifungal resistance in RVVC.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.